(Q33574585)

28 July 2017

title

Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography (English)

1 reference

28 July 2017

13

Jörg-Christian Tonn

0 references

Markus Holtmannspötter

10

object named as

Markus Holtmannspötter

1 reference

28 July 2017

9

Gabriele Pöpperl

1 reference

28 July 2017

Markus Schwaiger

14

0 references

Hans-Jürgen Wester

7

object named as

Hans-Jürgen Wester

1 reference

28 July 2017

Oliver Schnell

1

1 reference

28 July 2017

Bjarne Krebs

2

1 reference

28 July 2017

Janette Carlsen

3

1 reference

28 July 2017

Isabelle Miederer

4

1 reference

28 July 2017

Claudia Goetz

5

1 reference

28 July 2017

Roland H Goldbrunner

6

1 reference

28 July 2017

Roland Haubner

8

1 reference

28 July 2017

Hans A Kretzschmar

11

1 reference

28 July 2017

Horst Kessler

12

1 reference

28 July 2017

Ambros J Beer

15

1 reference

28 July 2017

publication date

1 December 2009

1 reference

28 July 2017

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

861-870

1 reference

Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Intraoperative MR-guided neurosurgery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Chemoradiotherapy in malignant glioma: standard of care and future directions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Positron emission tomography as an imaging biomarker

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

The WHO classification of tumors of the nervous system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Genetic pathways to glioblastoma: a population-based study

21 June 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-024

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-024

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-024

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-024

Quantification of [18F]diprenorphine kinetics in the human brain with compartmental and non-compartmental modeling approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-024

Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1215%2F15228517-2009-024

Chemotherapy for low-grade gliomas: emerging consensus on its benefits.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

[Recovery coefficients for the quantification of the arterial input functions from dynamic PET measurements: experimental and theoretical determination]

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Vascular integrin beta 3 and its relation to pulmonary metastasis of colorectal carcinoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2802406

Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival

31 October 2018

1 reference

12 December 2020

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas

1 reference

12 December 2020

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme

1 reference

12 December 2020

Reproducibility of metabolic measurements in malignant tumors using FDG PET

1 reference

12 December 2020

10.1215/15228517-2009-024

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference